Literature DB >> 29704059

Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study.

Emanuele Zaffuto1,2, Marco Bandini3,4, Stéphanie Gazdovich2, Anne-Sophie Valiquette2, Sami-Ramzi Leyh-Bannurah2,5, Zhe Tian2,6, Paolo Dell'Oglio1, Markus Graefen5, Marco Moschini1, Andrea Necchi7, Shahrokh F Shariat8, Alberto Briganti1, Francesco Montorsi1, Pierre I Karakiewicz2.   

Abstract

OBJECTIVE: To examine the rates of adherence to guidelines for pelvic lymph node dissection (PLND) in patients treated with radical cystectomy (RC) and to identify predictors of omitting PLND.
MATERIALS AND METHODS: We relied on 66,208 patients treated with RC between 2004 and 2013 within the National Inpatients Sample (NIS) database. We examined the rates of PLND according to year of surgery, patient and hospital characteristics. Univariate and multivariate logistic regression analyses assessed the probability of PLND use, after adjusting for year of surgery, age, gender, race, comorbidities, hospital location, teaching status and hospital surgical volume.
RESULTS: Overall, PLND was performed on 54,223 (81.9%) RC patients. The rates PLND at RC significantly increased over the study period from 72.3% in 2004 to 85.9% in 2013, (p < 0.001). Barriers to PLND at RC consisted of female gender (OR: 1.31; 95% CI 1.25-1.38; p < 0.001), African American race (OR: 1.21; 95% CI 1.10-1.32; p < 0.001), intermediate (OR: 1.78; 95% CI 1.68-1.88; p < 0.001) or low surgical volume institutions (OR: 2.59; 95% CI 2.44-2.74; p < 0.001), non-teaching institution status (OR: 1.21; 95% CI 1.15-1.27; p < 0.001) and rural hospital location (OR: 1.13; 95% CI 1.01-1.25; p = 0.03).
CONCLUSIONS: It is encouraging to note increasing rates of PLND at RC over time. Both patients and hospital characteristics influence PLND rates. More efforts should be aimed at reducing inequalities in PLND at RC due to these highly modifiable variables.

Entities:  

Keywords:  Bladder cancer; Guidelines adherence; Lymph nodes; NIS; Radical cystectomy

Mesh:

Year:  2018        PMID: 29704059     DOI: 10.1007/s00345-018-2306-7

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  19 in total

1.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

2.  Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004.

Authors:  Nicholas J Hellenthal; Michelle L Ramírez; Christopher P Evans; Ralph W deVere White; Theresa M Koppie
Journal:  J Urol       Date:  2009-04-16       Impact factor: 7.450

3.  Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.

Authors:  Firas Abdollah; Maxine Sun; Jan Schmitges; Orchidee Djahangirian; Zhe Tian; Claudio Jeldres; Paul Perrotte; Shahrokh F Shariat; Francesco Montorsi; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2011-08-24       Impact factor: 5.588

4.  Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.

Authors:  Badrinath R Konety; Sue A Joslyn; Michael A O'Donnell
Journal:  J Urol       Date:  2003-03       Impact factor: 7.450

Review 5.  Treatment of muscle-invasive bladder cancer: A systematic review.

Authors:  Roger Chou; Shelley S Selph; David I Buckley; Katie S Gustafson; Jessica C Griffin; Sara E Grusing; John L Gore
Journal:  Cancer       Date:  2016-01-15       Impact factor: 6.860

6.  Management of invasive bladder cancer: a meticulous pelvic node dissection can make a difference.

Authors:  D G Skinner
Journal:  J Urol       Date:  1982-07       Impact factor: 7.450

7.  Bladder Cancer, Version 5.2017, NCCN Clinical Practice Guidelines in Oncology.

Authors:  Philippe E Spiess; Neeraj Agarwal; Rick Bangs; Stephen A Boorjian; Mark K Buyyounouski; Peter E Clark; Tracy M Downs; Jason A Efstathiou; Thomas W Flaig; Terence Friedlander; Richard E Greenberg; Khurshid A Guru; Noah Hahn; Harry W Herr; Christopher Hoimes; Brant A Inman; Masahito Jimbo; A Karim Kader; Subodh M Lele; Joshua J Meeks; Jeff Michalski; Jeffrey S Montgomery; Lance C Pagliaro; Sumanta K Pal; Anthony Patterson; Elizabeth R Plimack; Kamal S Pohar; Michael P Porter; Mark A Preston; Wade J Sexton; Arlene O Siefker-Radtke; Guru Sonpavde; Jonathan Tward; Geoffrey Wile; Mary A Dwyer; Lisa A Gurski
Journal:  J Natl Compr Canc Netw       Date:  2017-10       Impact factor: 11.908

Review 8.  Gender and Bladder Cancer: A Collaborative Review of Etiology, Biology, and Outcomes.

Authors:  Jakub Dobruch; Siamak Daneshmand; Margit Fisch; Yair Lotan; Aidan P Noon; Matthew J Resnick; Shahrokh F Shariat; Alexandre R Zlotta; Stephen A Boorjian
Journal:  Eur Urol       Date:  2015-09-04       Impact factor: 20.096

9.  EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines.

Authors:  J Alfred Witjes; Eva Compérat; Nigel C Cowan; Maria De Santis; Georgios Gakis; Thierry Lebret; Maria J Ribal; Antoine G Van der Heijden; Amir Sherif
Journal:  Eur Urol       Date:  2013-12-12       Impact factor: 20.096

10.  Pelvic lymph node dissection can be curative in patients with node positive bladder cancer.

Authors:  J Vieweg; J E Gschwend; H W Herr; W R Fair
Journal:  J Urol       Date:  1999-02       Impact factor: 7.450

View more
  2 in total

1.  Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials.

Authors:  Marco Bandini; Alberto Briganti; Elizabeth R Plimack; Günter Niegisch; Evan Y Yu; Aristotelis Bamias; Neeraj Agarwal; Srikala S Sridhar; Cora N Sternberg; Ulka Vaishampayan; Christine Théodore; Jonathan E Rosenberg; Joaquim Bellmunt; Matthew D Galsky; Francesco Montorsi; Andrea Necchi
Journal:  Eur Urol Oncol       Date:  2018-09-07

Review 2.  Quality indicators for the management of muscle-invasive bladder cancer in the perioperative setting of radical cystectomy: a narrative review.

Authors:  Frederik König; Benjamin Pradere; Nico C Grossmann; Fahad Quhal; Pawel Rajwa; Ekaterina Laukhtina; Keiichiro Mori; Satoshi Katayama; Takafumi Yanagisawa; Hadi Mostafai; Reza Sari Motlagh; Abdulmajeed Aydh; Roland Dahlem; Shahrokh F Shariat; Michael Rink
Journal:  Transl Cancer Res       Date:  2022-04       Impact factor: 1.241

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.